American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

NewAmsterdam Pharma Co N.V. (NAMS)

$19.53 -0.91% NASDAQ: NAMS · 15-min delayed

NARRDEN, P7
Public · NASDAQ: NAMS
100 employees

Visit website Follow

$3.5BMarket cap

$22.5MRevenue · FY2025

-$203.8MNet income

100Employees

NAMSNASDAQ

2022IPO

About NewAmsterdam Pharma Co N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · NASDAQ: NAMS
Employees: 100
IPO date: Nov 23, 2022
Headquarters: GOOIMEER 2-35
NARRDEN, P7 1411 DC
Phone: 35 206 2971
Industry: Pharmaceuticals
Website: Visit site

Registry IDs

Ticker: NAMS Nasdaq
SEC CIK: 1936258
SIC: 2834 PHARMACEUTICAL PREPARATIONS

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show NewAmsterdam Pharma Co N.V.’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/newamsterdam-pharma-co-nv/"><img src="https://americancompanies.com/badge/newamsterdam-pharma-co-nv.svg" alt="NewAmsterdam Pharma Co N.V. — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow NewAmsterdam Pharma Co N.V. and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $22.5M
Net income: -$203.8M
Total assets: $769.3M
Market cap: $3.5B

Source: SEC EDGAR · updated Jun 8, 2026

NASDAQ: NAMS

$19.53 -0.91%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$19.53 $41.45

52-week range

Market cap: $3.5B
Shares outstanding: 177.4M
Open: —
Day range: –
Prev close: —
Volume: —
IPO date: Nov 23, 2022

NewAmsterdam Pharma Co N.V. (NAMS) Stock Price

Reported a net loss of $203.8M in FY2025.
Trading 53% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review NewAmsterdam Pharma Co N.V..

Write a review

Newsroom

News about NewAmsterdam Pharma Co N.V.

NewAmsterdam Pharma Announces Upcoming Presentations at the National Lipid Association (NLA) 2026 Scientific Sessions GlobeNewswire Inc. · 2026-06-03 · positive NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June GlobeNewswire Inc. · 2026-05-28 · positive NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. · 2026-05-01 · neutral NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire Inc. · 2026-04-02 · neutral NewAmsterdam Pharma to Present at the Guggenheim Emerging Outlook: Biotech Summit GlobeNewswire Inc. · 2026-02-04 · positive NewAmsterdam (NAMS) Q2 Revenue Jumps 49% The Motley Fool · 2025-08-07 · positive

News & sentiment via Polygon.io

FAQ

NewAmsterdam Pharma Co N.V.: frequently asked questions

Is NewAmsterdam Pharma Co N.V. an American company?

NewAmsterdam Pharma Co N.V. is a US-based company headquartered in Narrden, P7, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is NewAmsterdam Pharma Co N.V. headquartered?

NewAmsterdam Pharma Co N.V. is headquartered in Narrden, P7, United States.

Is NewAmsterdam Pharma Co N.V. publicly traded?

Yes — NewAmsterdam Pharma Co N.V. is a publicly traded company. Its stock trades under the ticker symbol NAMS on the NASDAQ.

What does NewAmsterdam Pharma Co N.V. do?

NewAmsterdam Pharma Co N.V. is an American Pharmaceuticals company in the Health & Beauty sector.

Explore